Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
IPO
Common Stock
Private Placement
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income Net of Income Taxes
IPO
Private Placement
Total
Balance at Dec. 31, 2018     $ 140         $ 281,600 $ 11,181 $ 3     $ 292,924
Balance (in shares) at Dec. 31, 2018     139,618                    
Foreign currency translation adjustment                         (67)
Foreign currency translation adjustment                   (70)     (70)
Stock-based compensation               1,680         1,680
Common stock issued upon exercise of stock options               177         177
Common stock issued upon exercise of stock options (in shares)     65                    
Common stock issued upon vesting of restricted stock units (in shares)     38                    
Net income                 23,307       23,307
Balance at Dec. 31, 2019     $ 140         283,457 34,488 (67)     318,018
Balance (in shares) at Dec. 31, 2019     139,721                    
Foreign currency translation adjustment                   1,078     1,078
Stock-based compensation               5,984         5,984
Exchange of common stock for Series A preferred stock       $ 454 $ (260,686)     260,232          
Exchange of common stock for Series A preferred stock (in shares)       45,438 15,146                
Issuance of stock       $ 156       85,308         85,464
Issuance of stock (in shares)       15,568                  
Repurchase of vested options               (15,506)         (15,506)
Common stock issued under employee purchase plan               424         424
Common stock issued under employee purchase plan (in shares)     61                    
Common stock issued upon exercise of stock options               780         780
Common stock issued upon exercise of stock options (in shares)     255                    
Common stock issued upon vesting of restricted stock units (in shares)     185                    
Net income                 20,453       20,453
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     620,679 54,941 1,011     416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Foreign currency translation adjustment                   (1,782)     (1,782)
Shares repurchased for settlement of employee tax withholdings         $ (1,802)               (1,802)
Shares repurchased for settlement of employee tax withholdings (in shares)         50                
Issuance of common stock as consideration for acquisition     $ 1         22,525         22,526
Issuance of common stock as consideration for acquisition (in shares)     684                    
Stock-based compensation               21,887         21,887
Exchange of common stock for Series A preferred stock     $ 5 $ (610) $ 260,686     (260,081)          
Exchange of common stock for Series A preferred stock (in shares)     5,190 (61,006) (15,146)                
Issuance of stock $ 10 $ 1       $ 269,380 $ 29,999       $ 269,390 $ 30,000  
Issuance of stock (in shares) 9,977 1,111                      
Common stock issued under employee purchase plan               404         404
Common stock issued under employee purchase plan (in shares)     15                    
Common stock issued upon exercise of stock options     $ 5         12,435         $ 12,440
Common stock issued upon exercise of stock options (in shares)     4,782                   4,788
Common stock issued upon vesting of restricted stock units (in shares)     366                    
Net income                 29,308       $ 29,308
Balance at Dec. 31, 2021     $ 162   $ (1,802)     $ 717,228 $ 84,249 $ (771)     $ 799,066
Balance (in shares) at Dec. 31, 2021     162,347   50